Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Ardeparin: Difference between pages

Content deleted Content added

VisualWikitext

@@ Line 1: / Line 1: @@
+{{Short description|Pharmaceutical drug}}
-{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid [{{fullurl:Ardeparin_sodium|oldid=461572631}} 461572631] of page [[Ardeparin_sodium]] with values updated to verified values.}}
+{{Use dmy dates|date=March 2024}}
 {{Drugbox
 | Verifiedfields = changed
 | Watchedfields = changed
-| verifiedrevid = 457813015
+| verifiedrevid = 461745594
 | IUPAC_name = 6-[5-acetylamino-4,6-dihydroxy-2-(sulfooxymethyl)tetrahydropyran-3-yl]oxy-3-[5-(6-
 | image = Ardeparin.png
 | width = 450
+| alt =
-<!--Clinical data-->
+<!-- Clinical data -->
 | tradename =
-| Drugs.com = {{drugs.com|MTM|ardeparin_sodium}}
+| Drugs.com = {{drugs.com|MTM|ardeparin}}
 | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
+| pregnancy_category =
-| pregnancy_US = C
+| routes_of_administration = Injection
-| pregnancy_category =
+| ATC_prefix = None
+| ATC_suffix =
 | legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
 | legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
 | legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
-| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
+| legal_US = Rx-only
+| legal_US_comment =
-| legal_status = Withdrawn
+| legal_status =
-| routes_of_administration =
-<!--Pharmacokinetic data-->
+<!-- Pharmacokinetic data -->
 | bioavailability = 92%
 | protein_bound =
 | metabolism =
 | elimination_half-life =
 | excretion =
-<!--Identifiers-->
+<!-- Identifiers -->
-| CAS_number_Ref = {{cascite|correct|??}}
+| CAS_number_Ref = {{cascite|correct|CAS}}
-| CAS_number =
+| CAS_number = 9041-08-1
-| ATC_prefix = none
+| PubChem =
-| ATC_suffix =
-| PubChem =
 | DrugBank_Ref = {{drugbankcite|changed|drugbank}}
-| DrugBank = <!-- blanked - oldvalue: DB00407 -->
+| DrugBank = DB00407
-| UNII_Ref = {{fdacite|changed|FDA}}
-| UNII = <!-- blanked - oldvalue: N3927D01PB -->
-| ChEMBL_Ref = {{ebicite|changed|EBI}}
-| ChEMBL = <!-- blanked - oldvalue: 1201448 -->
 | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
-| ChemSpiderID = NA
+| ChemSpiderID = none
+| UNII_Ref = {{fdacite|correct|FDA}}
+| UNII = N3927D01PB
+| ChEMBL_Ref = {{ebicite|changed|EBI}}
+| ChEMBL = 1201448
-<!--Chemical data-->
+<!-- Chemical data -->
 | chemical_formula = (C<sub>26</sub>H<sub>40</sub>N<sub>2</sub>O<sub>36</sub>S<sub>5</sub>)<sub>n</sub>
-| molecular_weight = 5500–6500 [[Dalton (unit)|Daltons]] (average)
+| molecular_weight = 5500–6500 g/mol (average)
 }}
+'''Ardeparin''' (brand name '''Normiflo''') is an [[anticoagulant]]. It was used for the prevention of [[deep vein thrombosis]], but was withdrawn from the US market in 2000 for reasons unrelated to safety or efficacy.<ref>{{cite book | vauthors = Frishman WH, Cheng-Lai A, Chen J |title=Current cardiovascular drugs |date=2000 |publisher=Current Medicine |location=Philadelphia, Pa. |isbn=978-1-4615-6767-7 |page=90 |edition=3rd | chapter = Antithrombotic therapy | chapter-url=https://books.google.com/books?id=zP7jBwAAQBAJ&pg=PA90 }}</ref><ref>{{cite web | work = Drugs.com | url = https://www.drugs.com/mtm/normiflo.html | title = Normiflo | access-date = 23 January 2018 | archive-date = 19 February 2017 | archive-url = https://web.archive.org/web/20170219170906/https://www.drugs.com/mtm/normiflo.html | url-status = dead }}</ref><ref>{{cite web |title=Determination That Ardeparin Sodium Injection Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness |url=https://www.federalregister.gov/d/02-12874 |website=United States Food and Drug Administration |date=23 May 2002 |publisher=Federal Register |access-date=24 June 2022}}</ref>
+==References==
+{{reflist}}
+{{Antithrombotics}}
+{{Portal bar | Medicine}}
+[[Category:Heparins]]
+[[Category:Withdrawn drugs]]
+{{blood-drug-stub}}